Technical Analysis for DFFN - Diffusion Pharmaceuticals Inc.

Grade Last Price % Change Price Change
grade B 1.255 3.72% 0.05
DFFN closed unchanged on Wednesday, May 27, 2020, on 76 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Very Strong Up Up Up
Historical DFFN trend table...

Date Alert Name Type % Chg
Calm After Storm Range Contraction 3.72%
Wide Bands Range Expansion 3.72%
Volume Surge Other 3.72%
Wide Range Bar Range Expansion 3.72%
Parabolic Rise Strength 3.72%
Wide Bands Range Expansion 3.72%
Upper Bollinger Band Touch Strength 3.72%
Wide Bands Range Expansion 1.21%
1,2,3 Pullback Bullish Bullish Swing Setup 20.67%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 20.67%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Diffusion Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing products for ophthalmology, oncology, and dermatology. Its lead product candidate is transcrocetinate sodium, which is in Phase I/II clinical trials for re- oxygenating treatment-resistant tissue; and making the cancer cells more susceptible to the therapeutic effects of radiation therapy and chemotherapy. The company is also developing RES-529, a novel PI3K/Akt/mTOR pathway inhibitor, which has completed two Phase I clinical trials for the treatment of macular degeneration; and is in pre-clinical development in oncology applications primarily glioblastoma multiforme. In addition, it is developing RES-440, a soft anti-androgen compound for the treatment of acne vulgaris. The company is headquartered in Charlottesville, Virginia.
Medicine Biotechnology Cancer Oncology Cancer Treatments Chemotherapy Radiation Radiation Therapy Glioblastoma Macular Degeneration Brain Tumor Signal Transduction Glioblastoma Multiforme Mtor Acne Vulgaris Oncology Applications

Is DFFN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 3.5637
52 Week Low 0.211
Average Volume 9,557,842
200-Day Moving Average 0.87
50-Day Moving Average 0.57
20-Day Moving Average 0.85
10-Day Moving Average 1.11
Average True Range 0.16
ADX 56.61
+DI 51.05
-DI 10.84
Chandelier Exit (Long, 3 ATRs ) 1.05
Chandelier Exit (Short, 3 ATRs ) 0.96
Upper Bollinger Band 1.43
Lower Bollinger Band 0.27
Percent B (%b) 0.81
BandWidth 136.02
MACD Line 0.19
MACD Signal Line 0.16
MACD Histogram 0.0294
Fundamentals Value
Market Cap 16.97 Million
Num Shares 14 Million
EPS -2.61
Price-to-Earnings (P/E) Ratio -0.46
Price-to-Sales 0.00
Price-to-Book 15.05
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.41
Resistance 3 (R3) 1.40 1.34 1.37
Resistance 2 (R2) 1.34 1.29 1.34 1.36
Resistance 1 (R1) 1.27 1.26 1.31 1.28 1.35
Pivot Point 1.21 1.21 1.22 1.21 1.21
Support 1 (S1) 1.14 1.16 1.18 1.15 1.07
Support 2 (S2) 1.08 1.13 1.08 1.06
Support 3 (S3) 1.01 1.08 1.05
Support 4 (S4) 1.02